OVID Message Board Post 9971142 | Ovid Therapeutics Inc.
home / stock / ovid / ovid message board
trueviet
(investorshub)
Posted on: Oct/29/2019 20:59:59
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151983348
Soticlestat Shows Promise for Developmental Epileptic Encephalopathies
News, Short Squeeze, Breakout and More Instantly...
-
Sustained exposure to OV329 in preclinical models reduced GABA-aminotransferase (GABA-AT) activity, increased steady state GABA levels in the brain, and induced phasic and tonic inhibition OV329 demonstrated anti-convulsant effects in mice, reducing the severity of status epilepticus and pr...
-
The Phase 1 study for OV888/GV101 capsule met its objective, demonstrating a favorable safety and tolerability profile with no serious adverse events Secondary endpoint results indicate that the target pharmacokinetic profile was achieved at the targeted clinical dose, supporting once daily d...
-
2024-06-18 10:30:03 ET B. Riley analyst issues BUY recommendation for OVID on June 18, 2024 09:12AM ET. The previous analyst recommendation was Buy. OVID was trading at $0.7744 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analy...